Skip to main content

Table 1 Veterans Health Administration and Department of Defense Clinical Practice Guideline for the management of Diabetes--Glycemic targets [13]

From: Diabetes treatment intensification and associated changes in HbA1c and body mass index: a cohort study

Comorbiditya or Physiologic age

Microvascular complicationsb

 

Absent/Mild

Moderate

Advanced

Absent

<7 %

<8 %

8–9 %

Life expectancy >10 years

(<53 mmol/mol)

(<64 mmol/mol)

(64–75 mmol/mol)

Comorbidity present

<8 %

<8 %

8–9 %

Life expectancy 5–10 years

(<64 mmol/mol)

(<64 mmol/mol)

(64–75 mmol/mol)

Multi Comorbidities

8–9 %

8–9 %

8–9 %

Life expectancy <5 years

(64–75 mmol/mol)

(64–75 mmol/mol)

(64–75 mmol/mol)

  1. aComorbidity includes, but is not limited to, any or several of the following conditions: cardiovascular disease, chronic kidney disease, chronic obstructive pulmonary disease, liver disease, stroke, and malignancy
  2. bMicrovascular disease includes complications of diabetes: retinopathy, nephropathy (micro or macroalbuminuria) and neuropathy